Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism. ijph [Internet]. 2012 Oct. 1 [cited 2026 Jul. 27];9(4). Available from: https://test-ojs-unimi-it.archicoop.it/index.php/ijphjournal/article/view/22676